People: Integra LifeSciences Holdings Corp (IART.OQ)
IART.OQ on NASDAQ Stock Exchange Global Select Market
38.61USD
1 Aug 2013
38.61USD
1 Aug 2013
Price Change (% chg)
$-0.78 (-1.98%)
$-0.78 (-1.98%)
Prev Close
$39.39
$39.39
Open
$39.50
$39.50
Day's High
$39.50
$39.50
Day's Low
$37.35
$37.35
Volume
69,154
69,154
Avg. Vol
46,431
46,431
52-wk High
$44.37
$44.37
52-wk Low
$30.89
$30.89
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Stuart Essig |
51 | 2012 | Chairman of the Board |
Peter Arduini |
48 | 2012 | President, Chief Executive Officer, Director |
John Henneman |
51 | 2012 | Corporate Vice President - Finance and Administration, Chief Financial Officer |
Padma Thiruvengadam |
48 | Chief Human Resources Officer, Corporate Vice President | |
Judith O'Grady |
62 | 2012 | Corporate Vice President - Global Regulatory Affairs, Corporate Compliance Officer |
John Mooradian |
57 | 2012 | Corporate Vice President - Global Operations and Supply Chain |
Jerry Corbin |
53 | 2009 | Corporate Vice President, Principal Accounting Officer, Corporate Controller |
Richard Gorelick |
52 | 2012 | Corporate Vice President, General Counsel, Administration, Secretary |
Robert Davis |
54 | Corporate Vice President, President - Neurosurgery | |
Brian Larkin |
44 | Corporate Vice President, President - Global Spine and Orthobiologics, and Head of Strategic Development | |
Debbie Leonetti |
57 | Corporate Vice President, President, International | |
Robert Paltridge |
50 | 2012 | Corporate Vice President, President - Extremity Reconstruction |
Dan Reuvers |
50 | Corporate Vice President, President - Surgical Instruments | |
Joseph Vinhais |
45 | Corporate Vice President - Global Quality Assurance | |
Keith Bradley |
68 | 1992 | Independent Director |
Richard Caruso |
69 | 2012 | Independent Director |
Lloyd Howell |
46 | 2013 | Independent Director |
Neal Moszkowski |
47 | 2006 | Independent Director |
Raymond Murphy |
65 | 2009 | Independent Director |
Christian Schade |
52 | 2006 | Independent Director |
James Sullivan |
69 | 1992 | Independent Director |
Angela Steinway |
IR Contact Officer |
Biographies
| Name | Description |
|---|---|
Stuart Essig |
Mr. Stuart M. Essig, Ph.D., is the Chairman of the Board of Integra LifesSciences Holdings Corporation. He has been Chairman since January 2012. He also served as Chief Executive Officer from December 1997 until January 2012, and President from December 1997 until November 2010. In addition, he has served as a director since he joined Integra in December 1997. Before joining Integra, Dr. Essig supervised the medical technology practice at Goldman, Sachs & Co. as a Managing Director. Dr. Essig had ten years of broad health care experience at Goldman Sachs serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients. Dr. Essig currently serves on the Board of Directors of St. Jude Medical Corporation and as Chairman of the Board of Directors of Breg, Inc. He is a founding investor member of Tigerlabs, a Princeton-based accelerator. He is an Executive in Residence at Cardinal Partners and a Venture Partner at Wellington Partners Advisory AG, both venture capital firms and serves as a Senior Advisor to TowerBrook Capital Partners. From March 2005 until August 2008, he served on the Board of Directors of Zimmer Holdings, Inc., and from 1998 to 2002 he served on the Board of Directors of Vital Signs, Inc. Dr. Essig has also served on the executive committee, nominating and governance committee and as treasurer of ADVAMED, the Advanced Medical Technology Association. Dr. Essig is also involved in several non-profit charitable organizations, including from time to time having served on the boards of such organizations. Dr. Essig received an A.B. degree, and graduated with magna cum laude honors from the Woodrow Wilson School of Public and International Affairs at Princeton University and an M.B.A. and a Ph.D. degree in Financial Economics from the University of Chicago, Graduate School of Business. |
Peter Arduini |
Mr. Peter J. Arduini is President, Chief Executive Officer, Director of Integra LifesSciences Holdings Corporation since January 3, 2012. He joined Integra in November 2010 as President and Chief Operating Officer and was appointed Chief Executive Officer and a director in January 2012. Before joining Integra, Mr. Arduini was Corporate Vice President and President of Medication Delivery, Baxter Healthcare, which he joined in 2005. Mr. Arduini was responsible for a $4.8 billion global division of Baxter. Prior to joining Baxter, Mr. Arduini worked for General Electric Healthcare, where he spent much of his 15 years in a variety of management roles for domestic and global businesses. Prior to joining General Electric Healthcare, he spent four years with Procter and Gamble in sales and marketing. Mr. Arduini serves on the Board of Directors of ADVAMED, the Advanced Medical Technology Association, and the Board of Directors of the National Italian American Foundation. Mr. Arduini received his bachelor's degree in marketing from Susquehanna University and a master's in management from Northwestern University's Kellogg School of Management. |
John Henneman |
Mr. John B. Henneman, III, is Corporate Vice President - Finance and Administration, Chief Financial Officer of Integra LifesSciences Holdings Corporation. He is responsible for the Company's finance department, including accounting and financial reporting, budgeting, internal audit, tax, and treasury. In addition, he is responsible for information systems, business development, the law department and investor relations. Mr. Henneman was appointed Integra's Corporate Vice President in December 2012, and has been Integra's Executive Vice President since February 2003, was Chief Administrative Officer from February 2003 until May 2008 and was Acting Chief Financial Officer from September 2007 until May 2008, when he was appointed Chief Financial Officer. Mr. Henneman was General Counsel from September 1998 until September 2000 and Senior Vice President, Chief Administrative Officer and Secretary from September 2000 until February 2003. Mr. Henneman received an A.B. degree from Princeton University and a J.D. from the University of Michigan Law School. |
Padma Thiruvengadam |
Ms. Padma Thiruvengadam is Chief Human Resources Officer, Corporate Vice President of Integra LifeSciences Holdings Corporation. She is responsible for providing leadership in developing and executing human resources strategy in support of the overall business plan and strategic direction of the organization. She is also responsible for Integra's strategic initiatives and program management. Ms. Thiruvengadam was appointed Integra's Corporate Vice President in December 2012. Previously, from September 2011 to December 2012, Ms. Thiruvengadam served as Integra's Chief Human Resources Officer. Prior to joining Integra, Ms. Thiruvengadam held several leadership positions at Pfizer, Inc., from 2008 to 2012, including Vice President, Global Human Resources for Oncology. She led the Wyeth integration globally for oncology and also served as Vice President, Oncology Asia-Pacific/Canada Operations. Prior to joining Pfizer, Ms. Thiruvengadam served as a Senior Vice President, Human Resources Executive at Bank of America, from 2005 to 2007, and as Executive Vice President, Human Resource, at Loral Skynet—Loral Space and Communications, from 2001 to 2004. Ms. Thiruvengadam completed her Master's program from Madras University and her Bachelor's from Osmania University. |
Judith O'Grady |
Ms. Judith E. O'Grady is Corporate Vice President - Global Regulatory Affairs, Corporate Compliance Officer of Integra LifesSciences Holdings Corporation. She was appointed Integra's Corporate Vice President in December 2012. Prior to that, Ms. O'Grady was Senior Vice President of Regulatory Affairs, and Corporate Compliance Officer from September 2012 to December 2012, and Senior Vice President, Regulatory Affairs, Quality Assurance, and Corporate Compliance Officer from 2007 to September 2012. Previously, she was Vice President of Regulatory Affairs, Quality Assurance and Clinical Affairs. Ms. O'Grady has worked in the areas of medical technology and collagen technology for over 25 years. Prior to joining Integra, Ms. O'Grady worked for Colla-Tec, Inc., a Marion Merrell Dow Company. During her career she has held positions with Surgikos, a Johnson & Johnson Company, and was on the faculty of Boston University College of Nursing and Medical School. Ms. O'Grady led the team that obtained the approval of the Food and Drug Administration ("FDA") for INTEGRA® Dermal Regeneration Template, the first regenerative product approved by the FDA, and has led teams responsible for approvals of the Company's other regenerative product lines as well as more than 600 FDA and international submissions. Ms. O'Grady received a B.S. degree from Marquette University and M.S.N. in Nursing from Boston University. |
John Mooradian |
Mr. John Mooradian is Corporate Vice President - Global Operations and Supply Chain of Integra LifeSciences Holdings Corporation. His responsibilities include global manufacturing and supply chain. Mr. Mooradian was appointed Integra's Corporate Vice President in December 2012. He joined Integra in September 2012 as Senior Vice President, Global Operations and Supply Chain. Before coming to Integra, Mr. Mooradian spent 24 years at Abbott Laboratories in a series of leadership roles. Prior to Abbott, Mr. Mooradian held several positions at General Motors. Mr. Mooradian received a B.B.A. degree in Management from the University of Texas, Arlington. |
Jerry Corbin |
Mr. Jerry E. Corbin is Corporate Vice President, Principal Accounting Officer, Corporate Controller of Integra LifesSciences Holdings Corporation. He is responsible for US GAAP and statutory financial reporting, accounting principles and policies and tax accounting. Mr. Corbin was appointed Integra's Corporate Vice President in December 2012. He has been Integra's Corporate Controller and Principal Accounting Officer since 2006. Prior to joining Integra in 2006, Mr. Corbin held key finance positions in corporate accounting, sales and marketing and research and development for Sanofi-Aventis and its predecessors from 1989 to 2006. Prior to that, he held management positions with Sigma-Aldrich Corporation and Edward D. Jones & Company and he gained his initial auditing experience with Arthur Andersen & Company. Mr. Corbin received a B.S. degree from Illinois State University and is a certified public accountant. |
Richard Gorelick |
Mr. Richard D. Gorelick is Corporate Vice President, General Counsel, Administration, Secretary of Integra LifeSciences Holdings Corporation. Mr. Gorelick was appointed Integra's Corporate Vice President in December 2012. He joined Integra as Vice President and General Counsel in 2000, and was appointed Senior Vice President and Corporate Secretary in 2006. Mr. Gorelick also chaired the Human Resources Department from 2008 to 2011. In September 2011, Mr. Gorelick was given the additional responsibilities of Corporate Communications, Environmental, Health and Safety, Sustainability, Government Relations and Public Policy, Risk Management, and the Integra Foundation. Prior to joining Integra, he spent four and a half years at Aventis Behring LLC, in biologics (plasma proteins) as Associate General Counsel, where his practice focused on technology licensing, strategic alliances, acquisitions and managing commercial litigation. Prior to that, Mr. Gorelick worked in the Business and Finance Section of Morgan, Lewis & Bockius LLP, in Philadelphia, where his practice concentrated on transactions, corporate reorganizations, creditors' rights and secured transactions. Mr. Gorelick received his A.B. degree from Princeton University and a J.D. degree from the University of California at Berkeley School of Law. |
Robert Davis |
Mr. Robert T. Davis, Jr., is Corporate Vice President, President - Neurosurgery of Integra LifeSciences Holdings Corporation. He is responsible for US GAAP and statutory financial reporting, accounting principles and policies and tax accounting. Mr. Corbin was appointed Integra's Corporate Vice President in December 2012. He has been Integra's Corporate Controller and Principal Accounting Officer since 2006. Prior to joining Integra in 2006, Mr. Corbin held key finance positions in corporate accounting, sales and marketing and research and development for Sanofi-Aventis and its predecessors from 1989 to 2006. Prior to that, he held management positions with Sigma-Aldrich Corporation and Edward D. Jones & Company and he gained his initial auditing experience with Arthur Andersen & Company. Mr. Corbin received a B.S. degree from Illinois State University and is a certified public accountant. |
Brian Larkin |
Mr. Brian Larkin is Corporate Vice President, President - Global Spine and Orthobiologics, and Head of Strategic Development of Integra LifeSciences Holdings Corporation. His responsibilities include executive oversight and leadership of Integra's worldwide Spine and Orthobiologics businesses, in addition to executive oversight of several of Integra's corporate functions, including marketing and strategic planning. Mr. Larkin was appointed Integra's Corporate Vice President in December 2012. He joined Integra in January 2000 as a Regional Sales Manager. He was promoted to National Sales Manager in 2003, Vice President, North American Sales in 2005, and President of Integra's Neurosurgery business in 2007. In 2010 he was appointed President, Global Spine & Orthobiologics, and Head of Strategic Development. Mr. Larkin has over 20 years of sales, marketing, and executive management experience in the medical technology industry. Prior to joining Integra, he was the National Sales Manager for Connell Neurosurgical. Mr. Larkin received a B.S. degree in Chemistry from the University of Richmond, and completed the Advanced Management Program at Harvard Business School. |
Debbie Leonetti |
Ms. Debbie Leonetti is Corporate Vice President, President, International of Integra LifeSciences Holdings Corporation. Ms. Leonetti was appointed Integra's Corporate Vice President in December 2012. She joined Integra in 1997 as Director of Marketing, was promoted to Vice President of Marketing in April 1999, Senior Vice President of Global Marketing in May 2004, Chief Marketing Officer in September 2007, President of Latin America, Asia Pacific and Canada (LAPAC) in 2008, and President of Integra Surgical in 2009. In 2010, Ms. Leonetti was appointed President of Integra's Instrument business and LAPAC. She was appointed President, International, in 2011. From 1989 through 1997, Ms. Leonetti worked for Cabot Medical, which was later acquired by Circon Corporation, and held positions in sales, sales training, and marketing. Prior to her experience at Cabot-Circon, Ms. Leonetti completed fifteen years of clinical practice as a registered nurse at St. Christopher's Hospital for Children in Philadelphia. Ms. Leonetti received her Nursing degree from St. Joseph's Hospital School of Nursing and La Salle University. |
Robert Paltridge |
Mr. Robert D. Paltridge is Corporate Vice President, President - Extremity Reconstruction of Integra LifeSciences Holdings Corporation. His responsibilities include the Extremity Reconstruction business to increased growth and profitability. Mr. Paltridge was appointed Integra's Corporate Vice President in December 2012. He joined Integra as National Sales Director in 1995, served as Vice President, North American Sales since 1997, was promoted to Senior Vice President, Global Sales in 2003 and promoted to President, Extremity Reconstruction in 2006. Mr. Paltridge has 28 years of sales and sales management experience in the medical technology industry. Before joining Integra, he was National Sales Manager at Strato Medical, a division of Pfizer, Inc. Mr. Paltridge received a B.S. degree in Business Administration from Rutgers University. |
Dan Reuvers |
Mr. Dan Reuvers is Corporate Vice President, President - Surgical Instruments of Integra LifeSciences Holdings Corporation. His responsibilities include global sales, marketing and product development for Integra's acute and alternate site instrument businesses. Mr. Reuvers was appointed Integra's Corporate Vice President in December 2012. He joined Integra in 2008 as Vice President of Marketing and Product Development for Integra's surgical business and was promoted to President of the acute surgical business in June 2010. He was appointed President, Instruments in 2011. Mr. Reuvers was President of Omni-Tract Surgical from September 2005 until December 2008, when the company was acquired by Integra. Mr. Reuvers has over 25 years of experience in the medical technology field, including holding various executive level positions in sales, marketing and general management. He serves on the board of directors of Respirtech, Inc. |
Joseph Vinhais |
Mr. Joseph Vinhais is Corporate Vice President - Global Quality Assurance of Integra LifeSciences Holdings Corporation. His responsibilities include strategic direction for corporate compliance and quality systems. Mr. Vinhais joined Integra in September 2012 as Senior Vice President, Global Quality Assurance, and was appointed Corporate Vice President in December 2012. Mr. Vinhais has over 20 years of global quality experience in quality assurance, regulatory affairs, compliance, and operations execution. Prior to joining Integra, Mr. Vinhais was head of Quality Assurance, Regulatory Affairs, and Sustainability at Philips Healthcare Imaging Systems, from 2009 to September 2012, where he was responsible for quality assurance and regulatory affairs for the Computed Tomography and Nuclear Medicine business. Prior to Philips, Mr. Vinhais was General Manager of Quality Assurance & Regulatory Affairs at General Electric Healthcare, from 2007 to 2009. Mr. Vinhais received a B.S. in Information Sciences and Systems from Central Connecticut State University, a certificate in Medical Device Management from Worcester Polytechnic Institute, and a certificate in Regulatory Affairs and Compliance from Northeastern University. |
Keith Bradley |
Dr. Keith Bradley, Ph.D., is an Independent Director of Integra LifesSciences Holdings Corporation since 1992. Between 1996 and 2003, he was a director of Highway Insurance plc, an insurance company listed on the London Stock Exchange, and has been a consultant to a number of business, government and international organizations. Dr. Bradley was formerly a visiting professor at the Harvard Business School, Wharton and UCLA, a visiting fellow at Harvard's Center for Business and Government and a professor of international management and management strategy at the Open University and Cass Business School, U.K. Dr. Bradley has taught at the London School of Economics and was the director of the School's Business Performance Group for more than six years. He previously served as a director and chair of North Star Capital Management Limited and GRS Financial Solutions Limited. |
Richard Caruso |
Dr. Richard E. Caruso, Ph.D., is an Independent Director of Integra LifesSciences Holdings Corporation. He founded the Company in 1989 and served as the Company's Chairman from March 1992 until January 2012 and as a director since March 1992. Dr. Caruso is currently the President and a member of The Provco Group, a venture and real estate investment company, an advisor to Quaker BioVentures, a medical venture capital financial investor, a member of the Board of Directors of Camel City Solar, LLC, a development stage solar energy company, a member of the Board of Directors of Diasome Pharmaceuticals, LLC, a start-up company, and an advisor to NewSpring Capital and ePlanet Ventures II, both diversified venture capital financial investors. Further, he serves as the Chief Executive Officer of Smart Personalized Medicine, LLC and President of Manage RightLite, LLC. Dr. Caruso served as the Company's Chief Executive Officer from March 1992 to December 1997 and also as the Company's President from September 1995 to December 1997. From 1969 to 1992, Dr. Caruso was a principal of LFC Financial Corporation, a project finance company, where he was also a director and Executive Vice President. In 2006, Dr. Caruso was named the Ernst and Young National Entrepreneur of the Year for the United States. Dr. Caruso is on the Board of Susquehanna University, The Baum School of Art and the Uncommon Individual Foundation (Founder). He received a B.S. degree from Susquehanna University, an M.S.B.A. degree from Bucknell University, a Ph.D. degree from the London School of Economics, University of London (United Kingdom) and an honorary Ph.D. degree in medical engineering from Drexel University. |
Lloyd Howell |
Mr. Lloyd W. Howell, Jr., is Independent Director of Integra Lifesciences Holdings Corporation since March 18, 2013. He is an Executive Vice President at Booz Allen Hamilton, where he has held a variety of leadership positions since originally joining the firm in 1988 as a consultant. He serves as the Civil Market Group Leader of Booz Allen Hamilton. From 2009 to 2013, he served as the Client Service Officer of the Financial Services Account in the Civil Market at Booz Allen Hamilton where he led the business in delivering the firm's strategic, technology and analytics capabilities and service offerings to both the federal and private sectors. From April 2005 to April 2009, he served as the Strategy and Organization's Capability Leader at Booz Allen Hamilton, a group that he has been a member of since 1995. Prior to that, from 1993 to 1995, he worked at Goldman Sachs as an Associate in their Investment Banking Division. Currently, Mr. Howell is a board member of the United Negro College Fund, Partnership for Public Service, Capital Partners for Education, Management Leadership for Tomorrow and the Committee for Economic Development. Mr. Howell received a B.S. in Electrical Engineering from the University of Pennsylvania and an M.B.A. from Harvard University. |
Neal Moszkowski |
Mr. Neal Moszkowski is an Independent Director of Integra LifesSciences Holdings Corporation since August 2006. He previously served as a director of the Company from March 1999 to May 2005. He has been the Co-Chief Executive Officer of TowerBrook Capital Partners L.P., an investment management firm, since 2005. Mr. Moszkowski served on the board of directors of the following public companies: Bluefly, Inc., Wellcare Health Plans, Inc., Spheris, Inc. and Jetblue Airways Corporation. Currently, he serves as a director of several privately-owned companies. Mr. Moszkowski earned his B.A. with magna cum laude honors in Economics and History from Amherst College in 1988. In addition, he received his M.B.A. from the Stanford University Graduate School of Business in 1993. |
Raymond Murphy |
Mr. Raymond G. Murphy is an Independent Director of Integra LifesSciences Holdings Corporation since April 2009. Between 2004 and 2008, he was Senior Vice President & Treasurer of Time Warner, Inc., responsible for all U.S. and international corporate finance, project (real estate and film) finance, cash management, foreign exchange and interest rate risk management, public debt and equity financing, real estate financing, securitization financing, banking relationships and financings, and relationships with rating agencies, as well as corporate-wide real estate activities and the property/casualty risk management program. Between 2001 and 2004, he was Vice President & Treasurer of Time Warner Inc. From 1999 until 2001, he was Senior Vice President & Treasurer of America Online, Inc. Between 1993 and 1999, he was Senior Vice President, Finance & Treasurer of Marriott International, Inc. Prior to Marriott, he held executive positions at Manor Care, Inc., Ryder System Inc. and WR Grace & Company. Since 2005, he has been a member of the Finance Committee of The Advertising Council Inc. and from 2007 until 2009, he served as Chair of such committee. Between 2004 and 2009, he served on the Board of Directors of The Advertising Council, Inc. and between 2007 and 2009, he served on its Executive Committee. He received a B.S. from Villanova University and an M.B.A. from Columbia University Graduate School of Business. |
Christian Schade |
Mr. Christian S. Schade is an Independent Director of Integra LifesSciences Holdings Corporation since 2006. He has been Executive Vice President and Chief Financial Officer of Omthera Pharmaceuticals, Inc. since September 2011. Omthera is a privately held, emerging specialty pharmaceuticals company focusing on the clinical development of new therapies for dyslipidemia. From April 2010 to September 2011, Mr. Schade served as Executive Vice President and Chief Financial Officer at NRG Energy, a NYSE listed, S&P 500 wholesale power generation company based in Princeton, NJ. While there, he was responsible for corporate financial functions, including Treasury, Accounting, Tax, Risk, Credit Management and Insurance. Prior to joining NRG, he was Senior Vice President Administration and Chief Financial Officer at Medarex Inc., a NASDAQ listed, Princeton-based biopharmaceutical company. He also helped Medarex to grow to become a pharmaceutical development company, raising capital through a series of public capital market and asset monetization transactions. While there, he also oversaw the manufacturing of multiple development/clinical programs and was responsible for the business development team. Before joining Medarex in 2000, Mr. Schade served as Managing Director at Merrill Lynch in London, where he was head of the European Corporate Funding Group and was responsible for certain capital markets activities of Merrill Lynch's European corporate clients. He also held various corporate finance and capital markets positions in New York and London for both Merrill Lynch and JP Morgan Chase & Co. Mr. Schade currently serves as Chair of the Board of Trustees at Princeton Academy School. Mr. Schade received an A.B. degree from Princeton University, and received an M.B.A. from the Wharton School at the University of Pennsylvania. |
James Sullivan |
Mr. James M. Sullivan is an Independent Director of Integra LifesSciences Holdings Corporation since 1992. He is a Co-Founder of, and currently the Principal Advisor to, the Clover Investment Group. Between 1986 and April 2009, he held several positions with Marriott International, Inc. (and its predecessor, Marriott Corp.), including Vice President of Mergers and Acquisitions and Executive Vice President of Lodging Development. From 1983 to 1986, Mr. Sullivan was Chairman, President and Chief Executive Officer of Tenly Enterprises, Inc., a privately held company operating 105 restaurants. Prior to 1983, he held senior management positions with Marriott Corp., Harrah's Entertainment, Inc., Holiday Inns, Inc., Kentucky Fried Chicken Corp. and Heublein, Inc. He also was employed as a senior auditor with Arthur Andersen & Co. and served as a director of Classic Vacation Group, Inc. until its acquisition by Expedia, Inc. in March 2002. Mr. Sullivan received a B.S. degree in Accounting from Boston College and an M.B.A. degree from the University of Connecticut. |
Angela Steinway |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Stuart Essig |
506,669 |
Peter Arduini |
8,510,670 |
John Henneman |
3,006,340 |
Padma Thiruvengadam |
-- |
Judith O'Grady |
403,366 |
John Mooradian |
831,041 |
Jerry Corbin |
484,649 |
Richard Gorelick |
668,102 |
Robert Davis |
-- |
Brian Larkin |
-- |
Debbie Leonetti |
-- |
Robert Paltridge |
648,067 |
Dan Reuvers |
-- |
Joseph Vinhais |
-- |
Keith Bradley |
-- |
Richard Caruso |
-- |
Lloyd Howell |
-- |
Neal Moszkowski |
-- |
Raymond Murphy |
-- |
Christian Schade |
-- |
James Sullivan |
-- |
Angela Steinway |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Stuart Essig |
1,117,124 | 19,485,570 |
Peter Arduini |
0 | 0 |
John Henneman |
1,184,443 | 11,031,690 |
Padma Thiruvengadam |
0 | 0 |
Judith O'Grady |
99,900 | 629,987 |
John Mooradian |
0 | 0 |
Jerry Corbin |
0 | 0 |
Richard Gorelick |
0 | 0 |
Robert Davis |
0 | 0 |
Brian Larkin |
0 | 0 |
Debbie Leonetti |
0 | 0 |
Robert Paltridge |
1,023,746 | 1,071,933 |
Dan Reuvers |
0 | 0 |
Joseph Vinhais |
0 | 0 |
Keith Bradley |
0 | 0 |
Richard Caruso |
0 | 0 |
Lloyd Howell |
0 | 0 |
Neal Moszkowski |
0 | 0 |
Raymond Murphy |
0 | 0 |
Christian Schade |
0 | 0 |
James Sullivan |
0 | 0 |
Angela Steinway |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
O GRADY-CIENCEWICKI JUDITH E |
1,895 | $38.50 |
O GRADY-CIENCEWICKI JUDITH E |
105 | $38.50 |
DAVIS ROBERT T JR |
606 | $37.89 |
DAVIS ROBERT T JR |
1,320 | $0.00 |
PALTRIDGE ROBERT D |
540 | $36.70 |
CORBIN JERRY E |
135 | $36.70 |
LARKIN BRIAN |
487 | $36.70 |
LEONETTI DEBORAH A |
487 | $36.70 |
CORBIN JERRY E |
1,876 | $38.07 |
HOWELL LLOYD JR |
3,425 | $0.00 |
BRADLEY KEITH |
3,425 | $0.00 |
CARUSO RICHARD E |
2,055 | $0.00 |
MURPHY RAYMOND G |
2,055 | $0.00 |
HOWELL LLOYD JR |
2,055 | $0.00 |
HILL BARBARA BENTON |
2,055 | $0.00 |
SULLIVAN JAMES MICHAEL |
3,425 | $0.00 |
CARUSO RICHARD E |
3,425 | $0.00 |
HILL BARBARA BENTON |
3,425 | $0.00 |
ESSIG STUART M |
4,795 | $0.00 |
MOSZKOWSKI NEAL |
3,425 | $0.00 |
SCHADE CHRISTIAN S |
3,425 | $0.00 |
MURPHY RAYMOND G |
3,425 | $0.00 |
LARKIN BRIAN |
200 | $36.86 |
BRADLEY KEITH |
29 | $36.53 |
O GRADY-CIENCEWICKI JUDITH E |
1,000 | $39.00 |

